Yu Jung Kim
Seoul National University(KR)Tianjin Medical University Cancer Institute and Hospital(CN)Seoul National University Bundang Hospital(KR)Dana-Farber Cancer Institute(US)AstraZeneca (Canada)(CA)Osong Medical Innovation Foundation(KR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Palliative Care and End-of-Life Issues, Lung Cancer Research Studies, Cancer survivorship and care, Glioma Diagnosis and Treatment
Most-Cited Works
- → Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial(2020)489 cited
- → Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance(2012)330 cited
- → High EGFR gene copy number predicts poor outcome in triple-negative breast cancer(2014)290 cited
- → Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer(2022)267 cited
- → Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer(2014)249 cited
- →